Smith & Nephew (SNN) Other Working Capital Changes (2012 - 2023)
Smith & Nephew (SNN) posted quarterly Other Working Capital Changes of -$27.0 million for Q4 2024, up 3.57% year-on-year from -$26.1 million in Q1 2024, and up 3.57% on a QoQ basis from -$28.0 million in Q4 2023.
Smith & Nephew (SNN) Other Working Capital Changes (2012 - 2023) Analysis & Trends
Smith & Nephew (SNN) has reported Other Working Capital Changes for 11 consecutive years, with -$3.0 million the latest figure, recorded in Q4 2023.
- Quarterly Other Working Capital Changes fell 250.0% year-over-year to -$3.0 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was -$3.0 million (up 40.0% YoY) and the FY2023 annual result came in at $3.0 million, down 50.0% from the prior year.
- Other Working Capital Changes improved to -$27.0 million in Q4 2024 per SNN's latest filing, from -$28.0 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for SNN reached as high as -$27.0 million in Q4 2024 and fell as low as -$28.0 million in Q4 2023.
- A 5-year average of -$1.6 million and a median of -$3.0 million in 2023 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2021 — Other Working Capital Changes plunged 300.0% — and 2022, when it jumped 150.0%.
- Year by year, Other Working Capital Changes stood at -$5.0 million in 2019, then jumped by 140.0% to $2.0 million in 2020, then tumbled by 300.0% to -$4.0 million in 2021, then soared by 150.0% to $2.0 million in 2022, then plunged by 250.0% to -$3.0 million in 2023.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$3.0 million, $2.0 million, and -$4.0 million for Q4 2023, Q4 2022, and Q4 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -3.00 Mn |
| Dec 31, 2023 | -3.00 Mn |
| Dec 31, 2023 | -3.00 Mn |
| Dec 31, 2022 | 2.00 Mn |
| Dec 31, 2022 | 2.00 Mn |
| Dec 31, 2022 | 2.00 Mn |
| Dec 31, 2021 | -4.00 Mn |
| Dec 31, 2021 | -4.00 Mn |
| Dec 31, 2021 | -4.00 Mn |
| Dec 31, 2020 | 2.00 Mn |
| Dec 31, 2020 | 2.00 Mn |
| Dec 31, 2020 | 2.00 Mn |
| Dec 31, 2019 | -5.00 Mn |
| Dec 31, 2019 | -5.00 Mn |
| Dec 31, 2019 | -5.00 Mn |
| Dec 31, 2018 | -35.00 Mn |
| Dec 31, 2018 | -35.00 Mn |
| Dec 31, 2018 | -35.00 Mn |
| Dec 31, 2017 | -40.00 Mn |
| Dec 31, 2017 | -40.00 Mn |